A Multicentre, Randomized, Double-blind, Parallel-group Study To Compare The Efficacy Of Golimumab In Combination With Methotrexate (MTX) Versus MTX Monotherapy, In Improving Dactylitis And Enthesitis, In MTX Naïve Psoriatic Arthritis Patients.
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Golimumab (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms GO-DACT
- 22 Nov 2017 Status changed from recruiting to completed.
- 17 Jun 2017 Trial design presented at the 18th Annual Congress of the European League Against Rheumatism
- 13 Sep 2016 Planned primary completion date changed from 1 May 2016 to 1 Mar 2017.